Menu

Tag: Dual listings

Not what the doctor prescribed – but close enough

Last week, I wrote about the delay in the launch of Shanghai Fosun Pharmaceutical’s long awaited equity offering in Hong Kong. As was expected at the time, bookbuilding finally started on October 16 for what is an accelerated timetable (on account of the upcoming bank holiday) that will now see pricing on October 24, and listing and start of trading on October 30. read

, , , , , , China, Cornerstones, Dual listings... +4 more

HKEx does some Seoul searching

A hardly noticed piece of news was released by the Hong Kong exchange on August 30: companies incorporated in South Korea will now be allowed to list in Hong Kong. Korea will accordingly join a list of 19 other jurisdictions now recognised by the exchange – on top of the mainland, Bermuda, the Cayman Islands and, of course, Hong Kong itself. read

, , , , Dual listings, Hong Kong, Listing by introduction... +2 more

Asia ECM shows binary outcomes

HONG KONG (Dow Jones Banking Intelligence) – Despite a significant pipeline of deals, at this stage in the year ECM transactions in Asia remain very much characterized by binary outcomes. Large, eye- catching offerings generate significant amounts of investor demand, while less obvious – and perhaps more challenging – transactions (when they close) have posted poor returns for investors. read

, , , , , , China, Dual listings, Hong Kong... +4 more

Mongolia’s Erdenes TT snubs Hong Kong for IPO

HONG KONG (Dow Jones Investment Banker) – News last week that Mongolia’s Erdenes Tavan Tolgoi, which owns one of the world’s largest coking coal deposits, would drop – for now – Hong Kong as one of the listing locations for its long-awaited IPO came as a surprise to market observers. The reasons probably include a disappointing performance for relevant offerings in Hong Kong, disclosure issues, as well as a comparatively weaker depositary receipt platform. read

, , , , , Depositary receipts, Dual listings, Hong Kong... +3 more